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Abstrak
Latar belakang: Virus polio indigenous terakhir ditemukan di Indonesia tahun 1995 tetapi ancaman virus 
polio impor dan mutasi virus dari Oral Polio Vaccine (OPV) menjadi Vaccine Derived Poliovirus (VDPV) 
masih berlanjut. Tahun 1991 WHO mengembangkan Surveilans Acute Flaccid Paralysis (AFP) dan tahun 
2014, identifikasi virus polio dengan real-time reverse transcriptase Polymerase Chain Reaction (rRT-
PCR) mulai digunakan di Laboratorium Nasional Polio Pusat Biomedis dan Teknologi Dasar Kesehatan. 
Tujuan dari penggunaan rRT-PCR untuk mendapatkan metode yang cepat dan lebih baik dalam memantau 
sirkulasi dan mutasi virus polio.
Metode: Isolat polio positif diidentifikasi menggunakanan rRT PCR dengan kombinasi primer dan probe 
yang ditetapkan WHO. RNA virus di konversi ke cDNA menggunakan reverse transcriptase lalu diamplifikasi 
menggunakan taq polymerase. Produk PCR di deteksi dan diidentifikasi dengan hibridisasi menggunakan 
probe spesifik. Sintesis cDNA dan reaksi PCR menggunakan primer yang dilekatkan di probe. Kombinasi 
primer dan probe menghasilkan identifikasi serotipe dan intratypic differentiation (ITD) dari isolat virus. 
Hasil: Selama tahun 2014, NPL Jakarta menerima 604 kasus AFP dari surveilans dan  lima kasus 
terdeteksi positif mengandung virus polio. Semua spesimen positif mengandung virus polio yang berasal 
dari vaksin. Dua kasus positif virus polio tipe P2 (40%), satu kasus jenis virus polio P1 (20%), 1 kasus 
jenis virus polio P3 (20%) dan satu kasus virus polio campuran jenis P1 + P2 (20%).
Kesimpulan: Real-time PCR dapat digunakan di Laboratorium Polio Jakarta untuk membantu identifikasi 
virus Polio secara cepat. Tes ini dapat digunakan untuk memantau sirkulasi virus polio pada populasi 
yang rutin diimunisasi dengan OPV. (Health Science Journal of Indonesia 2016;7:27-31)
Kata kunci: ITD, Poliovirus, Identification, rRT-PCR
Abstract
Background: The last indigenous polio was detected in 1995 but the threat of wild type polio viruses and the 
mutation of Oral Polio Vaccine into Vaccine-Derived Poliovirus still continue. Since 1991, WHO has developed 
Acute Flaccid Paralysis (AFP) laboratory based surveillance. In 2014, the polioviruses identification by real-time 
Reverse Transcriptase Polymerase Chain Reaction (rRT-PCR), has been introduced to National Polio Laboratory 
(NPL) Center for Biomedical and Basic Technology of Health. The objective of the rRT-PCR application is to have 
faster and better diagnostic methods to monitor the circulation and mutation of polio viruses.
Methods: Isolate tested by rRT-PCR using a combination of primers and probe mentioned by WHO manual. 
The viral RNA is converted to cDNA using reverse transcriptase and amplified in a PCR reaction using Taq 
polymerase. The PCR products are detected and identified by hybridization with specific probes. The combination 
of primers and probes will result in the serotype identification and intratypic differentiation of poliovirus isolates.
Results: In 2014 NPL Jakarta received 604 AFP cases through the surveillance system, five cases found 
positive for polio viruses by culture. All of the specimens were positive for polio vaccine viruses. Two 
cases were polio virus type P2 (40%), one cases polio virus type P1 (20%), 1 case polio virus type P3 
(20%) and one case mix polio viruses type P1+P2 (20%). 
Conclusion: The real-time PCR assay was able to help the identification of polio viruses rapidly in Jakarta 
lab. The test can be utilized for monitoring the population routinely immunized with OPV. (Health Science 
Journal of Indonesia 2016;7:27-31)
Keywords: ITD, Poliovirus, Identification, rRT-PCR
Health Science Journal of IndonesiaSusanti and Setiawaty28
Since 1988 the World Health Organization (WHO) 
has started global polio eradication program as 
mandated by the World Health Assembly. Since 
this program started, the progress has been made as 
the number of polio cases decreased globally and 
the number of countries which reported endemic 
transmission is reduced.1-2 WHO has established an 
integrated virology surveillance network globally to 
monitor polio viruses transmission and circulation 
since 1990.1 The objective of this network is to 
provide comprehensive epidemiology and virology 
data as a tool for public health measures toward 
polio eradication programs.1 The monitoring of 
the poliovirus transmission through laboratory 
approach has been implemented in Indonesia since 
1991 which previously  based on clinical approach. 
Poliovirus  monitoring was performed in cases with 
Acute Flaccid Paralysis (AFP) symptoms since 1995 
as part of WHO global program. The integrative 
polio surveillance network in Indonesia was able to 
detect last wild-type poliovirus cases in 1995 and the 
polio importation cases in 2005.3 Since South East 
Asia region had been certified as polio-free region 
in 2014, the virology surveillance network is still 
needed to monitor the circulation and transmission 
of polio virus from other non-polio free region.4
The Global Polio Laboratory Network (GPLN) 
consists of three levels; Global Specialized 
Laboratory, Regional Reference Laboratories, and 
National Laboratories.1 Each levels has different 
responsibilities under the guideline set by WHO. In 
Indonesia, three laboratories have been designated 
as National Polio Laboratory (NPL) which act as 
national referral laboratory for poliovirus detection. 
Virology Laboratory Center for Biomedical and 
Basic Technology of Health (CBBTH), National 
Institute of Health Research and Development 
(NIHRD) acts as NPL for 16 provinces in the western 
part of Indonesia (all provinces on the island of 
Sumatra, Borneo and some in Java).5. As mentioned 
by the WHO polio laboratory manual, the main 
NPL activities is the virus isolation and serotype 
identification from AFP stool specimens received 
from national surveillance network.1 
Viral isolation is the “Gold Standard” laboratory 
methods performed in all laboratories under GPLN. 
The observation of cytopathic effect in L20B 
and RD cells after virus isolation determine the 
presence of enterovirus in the specimens.1 Poliovirus 
identification then can be performed using several 
methods such as neutralization, ELISA and hybri-
dization. These methods also provide intratypic 
differentiation (ITD) between wild type and vaccine 
derived polio virus.6,7 The ITD is performed by 
Regional Reference Laboratories (RRL).1 Since 
1999, the technique of Polymerase Chain Reaction 
(PCR) has been introduced to identify polioviruses 
from AFP specimens as part of the development 
of the polio identification methods that more 
accurate, quickly and reliable.5 In 2014, the new 
diagnostic method technique of real-time reverse 
transcriptase polymerase chain reaction (rRT-PCR) 
for the identification of positive isolates polio has 
been introduced in NPL CCBTH Jakarta. The 
objective of this introduction is to have faster and 
better diagnostic methods which will help monitor 
the poliovirus circulation and mutation as NPL can 
perform ITD using these methods. This article will 
report the progress of PCR technique introduction in 
NPL Jakarta in 2014.
METHODS
 
Stool specimens from AFP cases received from 
surveillance activities in 2014 were processed as WHO 
guidelines. Specimens were then inoculated into the 
Rhabdomyosarcoma (RD) and L20B cells. The grown 
virus in L20B cells than passage into RD cells. 50 μl of 
virus isolates grown in RD cells were spun at 5000 rpm 
for 2 minutes at room temperature. 
The RT-PCR method used in this procedure was 
described previously.8 The supernatant (0.5 μl) and 1 μl 
of control RNA as a positive control was added into 
each well or 0.2 ml tube strip were already contains a 
reagent which consists of 19 μl of buffer A (primers and 
probes) and 5 μl of buffer B has been added enzymes 
(2.8 mL of 1 M DTT, 27.6 mL of 40 U/ml RNase 
inhibitor, 18.0 mL of 20 U/ml transcription RT (14.4 
mL or 25 U/ml AMV RT) in 1 ml of buffer B). one well/
tube strips used as a negative control without added any 
template. The programs that used for PCR were 42°C, 
45 min for RT reaction, 95°C, 3 min for inactivation of 
RT (holding stage) and with dual-stage PCR cycles. 
RT PCR for ITD. This method had two-stages. 
Stage 1 of 15 cycles with the condition of 95°C for 
24 seconds, 44°C for 30 seconds, then 25% ramp 
speed and 65°C for 24 seconds. Followed by stage 
2 of 40 cycles with the condition of 95°C for 24 
seconds, 47°C for 30 seconds, then 25% ramp speed 
and 65°C for 24 seconds. Data were collected at the 
end of stage 2. If the results are expressed positive 
ITD sabin (SL) / vaccine as CT value between 10-
28, the curves should be compared with positive and 
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negative control. After this step, it would be followed 
by VDVP test.
RT PCR for VDVP. This method is similar to the 
ITD but differs in primer and probe in buffer A and 
its PCR cycles. A PCR cycle on VDVP test also has 
a dual stage. Stage 1 by 5 cycles with the condition 
of 95°C for 24 seconds, 44°C for 30 seconds and 
60°C for 24 seconds followed by a second stage of 
40 cycles with the condition of 95°C for 24 seconds, 
50°C for 30 seconds, and 25% ramp speed and 65°C 
for 24 seconds. If the result is positive (CT value 10-
28) then the specimens were concluded as a positive 
for polio virus from the vaccine. If the result is 
negative then it will be proceed with the sequencing.8
RESULTS 
Table 1 shows the number of AFP cases reported and 
the number of polio and non polio enterovirus (NPEV) 
positive by cultured every month. Fortunately, isolation of 
virus from stool extracts also cultured other enteroviruses/
NPEV. From January to December 2014 the National 
Polio Laboratory CBBTH NIHRD Jakarta received 604 
cases of AFP surveillance with 1227 specimens and only 
1% of AFP cases of AFP were positive of poliovirus and 
8% were positive of NPEV in the stool.
Table 2 shows the distribution of poliovirus and 
NPEV positive cases by age group and gender. The 
polio and NPEV positive cases in the age group 1-5 
is higher than the other age group. 
The positive isolates were identified using realtime PCR 
methods. Tabel 3 shows all of the polio viruses from AFP 
cases were sabin like and polio virus type 2 (P2). 
DISCUSSION
This study conducted on the specimens from 
AFP cases sent to NPL CBBTH during 2014. The 
results showed that not all AFP cases are caused 
by poliovirus, only 1% of AFP cases of AFP were 
positive of poliovirus. This result is similar to the 
result from previous research that Guillain Barre 
Syndrome is the most common cause in the AFP 
case.9,10 The results in several National Laboratories 
worldwide also showed that NPEV from AFP cases 
were quite high.11
Identification for poliovirus at AFP cases need 
more rapid and sensitive method. Realtime RT-PCR 
method more objective and faster than previous 
methods (neutralization test and hybridization) which 
takes a more time and need experience and skill.12 
Identification of poliovirus using Realtime RT-PCR 
method is performed on L20B positif cell cultures that 
show characteristic Cytopathic Effect (CPE).1
Realtime RT-PCR method utilizes multiple sets of 
oligonucleotide primers combined with probes to 
identify the serotypes and intratypic differentiation 
of poliovirus. This method can detect the presence 
of NPEV and poliovirus that mixture in the 
isolation medium. Realtime RT-PCR for poliovirus 
identification is designed with degenerate primer by 
targeting particular amino acid for each serotype of 
polioviruses. Degenerate primers are designed to 
compensate error due to nucleotides synthesized.8
Table1.Distribution ofpolioAFP casesand Positive
Month No of AFP Cases No of Specimens No. of Polio Positive Specimens  
No. of Polio Positive Specimens 
polio positive by PCR
No. of  NPEV 
Positive Specimens 
   
January 30 62 0 ( 0% ) 0 ( 0% )     2  ( 3% )
February 52 108 0 ( 0% ) 0 ( 0% )     5  ( 5% )
March 53 107 1 ( 2% ) 2 ( 2% )   13  (12%)
April 54 113 2 ( 4% ) 4 ( 4% )   10  ( 9% )
May 56 113 1 ( 2% ) 2 ( 2% )   16 (14% )
June 40 80 1 ( 3% ) 2 ( 3% )     8 (10% )
July 31 62 0 ( 0% ) 0 ( 0% )     6 (10% )
August 26 50 0 ( 0% ) 0 ( 0% )     1 ( 2% )
September 42 86 0 ( 0% ) 0 ( 0% )     2 ( 2% )
October 75 153 0 ( 0% ) 0 ( 0% )   11 ( 7% )
November 74 152 2 ( 3% ) 4 ( 3% )   14 ( 9% )
December 71 141 0 ( 0% ) 0 ( 0% )     9 ( 6% )
Total 604 1227 7 ( 1% ) 14 ( 1% )   97 ( 8% )
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Table 2. Demographic distribution of positive Polio and 
NPEV cases
Characteristics No of Cases No of Polio Positive (%)
No of NPEV 
Positive (%)
Age group 
(years old)
0 – 1 49 3 (6.1) 10 (20.4)
> 1 – 5 298 3 (1) 60 (20.1)
> 5 – 15 257 1 (0.4) 27 (10.5)
Sex
Male 326 4 (1.2) 66 (20.2)
Female 278 3 (1.1) 31 (11.1)
Table 3. Serotypes of Poliovirus from AFP cases
Serotype No. of Positive (%)
P1 Sabin Like 2 (14)
P1+P2 Sabin Like 2 (14)
P2 Sabin Like 8 (57)
P3 Sabin Like 2 (14)
Total 14 (100)
There are three types of polio virus circulating 
which are Sabin, VDPV and wild type. Sabin virus is 
obtained from the polio vaccine and as the virus can 
mutate in non-vaccinated or immunocompromised 
leading to VDPV with a 1% difference in nucleotide 
Sabin reference.  (REF) Currently, the wild polio 
virus was found only in the country of Pakistan, 
Afghanistan and Nigeria. (REF)
Poliovirus might infect people at any age and gender 
with the children under five years is more susceptible 
to the infection. The children in the age group 1-5 
years are susceptible than under 1 year because they 
are more active than the children under 1 year old. 
Moreover, the maternal immunity is assumed to 
protect the children under 1 year from poliovirus 
infection.13,14
Identification of poliovirus using Realtime RT-PCR 
method on three types of poliovirus found in the stool 
specimens from positive cases as showed in Table 3 
and P2. Sabin was the more common serotype (60%). 
The use of oral trivalent poliovirus vaccine (OPV) 
in Indonesia might cause the presence of poliovirus 
in stools because the virus still replicates in the 
intestine for several weeks after vaccination and 
then are excreted in the feces. There is competition 
among the three type viruses in the development of 
immunity. OPV is most effective against type 2. The 
type 2 virus from OPV replicated in intestine and is 
excreted in the stool. 1,15
In conclusion, the real-time PCR assay was able 
to help the identification of polio viruses rapidly in 
Jakarta lab. The test can be used for monitoring the 
mutation and circulation of poliovirus.
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